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CHF. Despite being significantly younger, they presented with high risk features and had 
a higher in hospital complication rate although similar unadjusted mortality rate. This 
study suggests that pts of SA ethnicity are a high risk subset of the CHF population who 
may benefit from more aggressive therapeutic intervention at an eedier age. 
1205-155 Mltral  Regurg i tat ion Is an Independent Risk Factor fo r  
Mortality in Patients With Heart Failure and Left  
Ventr icu lar  Systo l i c  Dysfunction 
Beniamin H. Tdchon, G. Michael Felker, Linda K. Shaw, Christopher H. Cabell, 
Christopher M. O'Connor, Duke Clinical Research Institute, Durham, North Carolina. 
Background: Mitral regurgitation (MR) is common in patients with heart failure (HF). 
However, mild MR accompanying left-ventdcular (LV) dysfunction is often minimized in 
practice and the relation between the severity of MR and survival is not well character- 
ized. 
Methods: We assessed the incidence of MR in patients with HF (-> NYHA II) and ejection 
fraction @,0% undergoing cardiac catheterization between 1986 and 2000. MR was 
graded as mild (grade 1+/2+) or moderate/severe (grade 3+/4+). 
Patients with other valvular disease were excluded. Baseline charactedstics of the popu- 
lation were defined. A multivariate Cox proportional hazards model was used to assess 
the independent effect of MR on survival. 
Results: 2057 patients met study cdteria. 1156 (56%) had MR identified. In 811 (70%), 
the MR was mild. Patients with MR were more likely to be older (63 vs. 60, p=O.001), 
female (43.4% vs. 28.9%, p=0.001), and have a gallop on exam (36.5% vs. 24.8%, 
p--O.001). Mean duration of follow-up = 3.4 years. 
Compared to those without MR, patients with mild and moderate/severe MR had an 18% 
(HR=1.18, 1.03-1.36, p=0.01) and 53% (HR=1.53, 1.29-1.82, p<0.001) increased risk of 
death, respectively (GRAPH). 
Conclusions: 
MR is common in patients with HF and systolic dysfunction. There is an independent, 
progressive relation between MR severity and mortality. Studies are needed to investi- 
gate the affect of therapies (mltral valve repair or cardiac re-synchronization) on out- 
comes in patients with MR accompanying LV dysfunction. 
MR Grade  and  eur~rlVal  In HF  Pa l te r  
1205-156 Prognosis of Women Compared With Men With Heart 
Failure end Acute Myocardial Infarction After Previous 
Revascularlzatlon 
Predrao M. Mitrovic, Zorana Vaslljevic-Pokrajcic, Branislav Stefanovic, Jovan Perunicic, 
Gordana Matic, Nebojse Radovanovic, Dubravka Rajic, Cardiology Clinic, institute for 
Cardiovascular Diseases, University Clinical Centre, Belgrade, Yugoslavia. 
Patients (pts) who have clinical evidence of congestive heart failure (CHF) after acute 
myocardial infarction (AMI) and previous coronary artery bypass grafting (CABG) have a 
poor prognosis. The aim of this prospective study was to analyze influence of gender on 
survival in pts with CHF and AMI after previous CABG. Methods: From April 1990 - 
August 2001 we studied 730 pts, who developed AMI after CABG, mean age 58.4+8.0 
years, mainly men (80.8%). The pts with eerly perioperative AMI were excluded from the 
study. All pts were followed-up 12 years. The average time interval from CABS to AMI 
was 96.2 ± 16.0 months. The average number of grafts was 3,4 grafts/pts. There were 
274/730 pts (37.5%) with signs of CHF. Clinical evidence of CHF was defined as at least 
two of the following: bibasilar ralas, third heart sound or/and interstitial or alveolar edema 
on chest radiograph. All pts were divided in two groups: group I - 89/274 (32.5%) female 
with CHF and AMI after previous CABG and group II - 185/274 (67,5%) male with CHF 
and AMI after previous CABG. Results: There was no statistical difference in age, 
CABG-AMI interval, number of grafts/pie, AMI location, infarct size and risk factors for 
coronary artery disease. There were differences between groups in: previous angina 
pectods (91% vs 56.8%, p<0.01), previous AMI (56.2% vs 31.3%, p<0.05), in-hospital 
mortality (15.7% vs 4.3%, p<0,05) and one-year mortality (40.4% vs 11.9%, p<0.01). 
Conclusion: This study suggests that female with signs of CHF and AMI after previous 
CABG had worse prognosis compared with male with CHF and AMI after previous 
CABG, specially in in-hospital and one-year padod; the predictors of that prognosis were 
previous angina pectods and previous AMI. 
1205-157 The Incremental Prognostic Sign i f i cance of  
Hyperurlcemla In African Americana With Severe Heart 
Fai lure 
Patricia A. Uber. Mandeep R. Mehra, Myung H. Park, Robert L. Scott, Ochsner 
Cardiomyopathy and Heart Transplantation Center, New Orleans, Louisiana. 
Background: Compared with Caucasians (C), African Americans (AA)exhibit higher uric 
acid levels, a marker of free radical generation. We sought to determine the clinical 
impact of hyperuricamia in AA with severe Heart Failure (HF).Methoda: 140 severe HF 
patients (52 +11 years, ejection fraction 20 :L-9%, 80% men, follow-up 12-72 months) 
awaiting heart transplantation were examined in order to evaluate the prognostic utility of 
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baseline uric acid levels (_>7.5 versus < 7.5 mg/dl) at listing for transplantation, as a func- 
tion of race. We analyzed detailed variables among the 106 C and 34 AA patients to 
assess variables predictive of HF hospitalizations or death in concert with hyperurice- 
mia.Reaulta: Baseline charactedstics were similar in AA and C with regard to age, EF%, 
NYHA class, serum sodium, bilirubin, creatinine and HF medications. AA were more 
likely than C's to, have hypertension (61% vs 40%, p =0.04), had a larger proportion of 
women (39% vs 13%, p = 0.007), and were more hyperudcemic (7.9 + 2.1 vs 6.8 ± 2.0, p 
= 0.006). The results of actuarial event free survival at 3 years are shown in the table. 
Group African Americana Caucasians p value 
Urlc Acld > 7.5mg/ 60% 71% 0.04 
dl 
Uric Acid < 7.5 rag/ 86% 80% ns 
dl 
p value 0.03 ns 
Multivariable analysis demonstrated that hyparudcamia occurred independent of diuretic 
use, renal function, age and gender.Conclusions: Hyperuricamia, a marker of oxidative 
stress, is prevalent in AA and represents a discriminatory marker of poor clinical outcome 
in severe HF. This investigation provides insight into ethnic differences in oxidative stress 
as a critical determinant of prognosis in heart failure. 
1205-158 Predict ion of  Morbidity and Morta l i ty  Fo l lowing 
Myocardial Infarction 
Kenneth Dickstain, Stevan Snappin, The OPTIMAAL Trial Study Group, Central Hospital 
in Rogaiand, Stavanger, Norway. 
Introduction: It is important to choose the most appropriata endpoints in clinical trials 
evaluating an intervention on morbidity and mortality. The ability of these events to pre- 
dict death impacts on patient selection and trial design. 
Methods: 5477 patients with acute myocardial infarction and left ventricular dysfunction 
have been randomised to treatment with either captopdl or Iosertan in the OPTIMAAL 
trial. During a mean follow-up period of 27 months there have been 584 patients with 
reinfarctions, 1561 patients with ravascularisation (PTCA/CABG), 2670 patients with car- 
diovascular (CV) hospltalisations and 780 deaths. 
Results; Baseline demographics contain powerful predictors for reinfarction, revascular- 
isation or hcspitalisetion. The ability of selected variables to predict a heart failure (HF) 
hospitalisation are displayed in the table. The increases in risk of death associated with 
cardiovascular endpoints were: HF hospitalisetion 746%, Rainfarction 502%, CV Hospi- 
talisation 290%, Revasculadsation -45% (P<0.001 in all cases). 
Conclusion: Morbid events following complicated MI are predicted by selected baseline 
demographic variables. Death is predicted by these morbid endpoints. A heart failure 
hospitalisetion was an especially powerful predictor for death. These data have implica- 
tions for the choice of patients and endpoints in clinical tdals seeking to assess the effi- 
cacy of an intervention on morbidity and mortality. 
Increases In Risk of a Heart Failure Hoapltalleatlon 
Baseline Risk Factor Clinical Status Prior to Randomization 
age (per year) 6% tachycardia 83% 
diabetes 62% X-ray congestion 81% 
atrial fibrillation 62% IV diuretics 77% 
prior diuretic 62% pulmonary rales 60% 
previous infarction 47% EF<35% 52% 
previous infarction 41% gallop rhythm 48% 
prior beta blocker 39% Killip class (per class) 58% 
P<O.O01 in all cases 
1205-159 Low Serum Total Cholesterol Is Associated With a 
Marked Increase in Mortality in Advanced Heart Fai lure 
Tamare B. Herwich, Machete A. Hamilton, Robb MacLellan, Gregg C, Fonarow, UCLA 
Medical Center, Los Angeles, California. 
Background: Although hypercholesterolemia is associated with CAD and cardiovascu- 
lar mortality, the relationship between choleeterot and heart failure (HF) mortality is less 
certain. 
Methods: Our study analyzed 1134 patients with advanced HF referred to a single cen- 
ter for transplant evaluation. The cohort was 75% men, etiology was 48% ischemic, and 
mean EF was 22%. Serum lipid panel was measured time of initial presentation. Patients 
were stratified into five groups based on quintiles of total cholesterol (TC) level. 
Resulta: HF etiology, HTN, DM, and lipid-lowering therapy at time of referral were similar 
among the 5 TC groups. Patients with lower TC had significantly lower levels of LDL, 
HDL, triglycarides (TG), sodium and albumin. The lower TC quintiles had lower EF and 
cardiac output, but higher wedge pressures and increased likelihood of NYHA class IV. 
Decreased TC, LDL, HDL, and TG each predicted increased mortality (p=0.01) on 
univadate analysis. After adjustment for known predictors of HF mortality including BMI, 
elevated TC was an independent predictor of improved survival (0.996 RR tor lmg/di 
increase), while LDL, HDL, and TG were not. See table for survival and relative dsk of 
each TC quintile. 
Conclusions: Low serum TC predicts HF outcomes independent of established mortality 
predictors, and thus represents a novel prognostic factor. Further investigations are nec- 
essary to determine whether a low TC level is merely a prognostic marker or is playing a 
causative role in HF mortality. 
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Five-year Mortality Rates of the Total Cholesterol Quintilea 
Total Cholesterol Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
(mg/dl) (<129) (129-160) (161-189) (190-223) (>223) 
N 




Risk (95% CI) 
Adjusted Relative 
Risk (95% CI) 
222 225 227 232 228 
137 108 103 77 72 
23.8% 35.1% 37.2% 51.6% 55.2% 
2.458 1.609 1.630 1.027 1.00 
(1.846-3.271) (1.194-2.168) (1.206-2.203) (0.744-1.416) 
1.946 1.386 1.732 1.043 1.00 
(1.242-3.047) (0.873-2.199) (1.079-2.082) (0,640-1.698) 
1205-160 Prognostic Implication of the Valsalva Manouver in 
Patients With Dilated Cardiomyopathy 
Andrea Rossi, Mariantonietta Cicoira, Giorgio Golia, Luisa Zanolla, Lorenzo 
Franceschini, Piero Zardini, Divisione di Cardiogia, Verona, Italy. 
In patients with dilated cardiomyopathy (DCM), restrictive mitral pattern (RMP) is a 
marker of diastolic dysfunction and of impaired survival. Pharmacologic unloading with 
nitroprusside discriminates between reversible and irreversible RMP adding important 
prognostic information to baseline mitral inflow pattern. We aimed to analyze whether 
ventricular unloading by means of the Valsalva manouver might give similar prognostic 
information. Methods: In 106 DCM pts (63_+12 years; 72% male), LV diastolic (LVD) and 
systolic (LVS) volumes and EF were measured from apical 4-chambers view (area-length 
method). Mitral E (E), A (A) wave velocities, their ratio (E/A) and E deceleration time 
(DTe) were measured. RMP was defined as E/A >2 or E/A > 1 and DTe < 140 msec. Non- 
RMP was defined as E/A < 1 or E/A > 1 and DTe >_ 140 msec. In patient with RMP, 
unloading was induced by the Valsalva manouver and mitrel inflow pattern was recorded 
close to the end of the strain phase (10 sec). During unloading the presence of RMP was 
defined as at baseline. Patients were divided in three groups: non-restrictive (Group 1 : 86 
pts), reversible-RMF (Group 2 :9  pts), irreversible-RMF (Group 3 :9  pts). Results: 
Kaplan-Meier survival curve is shown in the figure. Conclusion: In DCM patients the Val- 
salva manouver is a simple, rapid and useful tool to enhance prognostic assessment. 
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1205-162 Eff icacy, Tolerabi l i ty,  and Long-Term Effects of  
Carvedi lo l  in Women 
ChristoDher S. Allada, Anne M. Keogh, Eugene Koityar, Christopher S. Hayward, Peter 
S. Macdonald, St Vincent's Hospital, Sydney, Australia. 
Background: Women do not always exhibit the same physiological responses to heart 
failure therapy as do men. We wished to determine whether there are differences in toler- 
ance of, or responses to carvedilol between males and females. 
Methods: In a cohort of 70 women and 431 men started on open label carvedilol for 
NYHA functional class I-IV heart failure between February 1996 and May 2001, 51 
women (80%) and 346 men (80.7%) have remained on carvedilol for more than 12 
months. A com~arator group of men on oarvedilol greater than 12 months was found for 
the 51 women by matching for age, diagnosis, and NYHA functional class, and a retro- 
spective compahsion was conducted. 
Results: 
Women Baseline 3 months 6 months 12 months Change- 
(n=51) baseline to 
12 months 
NYHA 2.9 -+ 0.7 2.5 -+ 0.7 * 2.2 ± 0.7" 2.2 + 0.6 * - 24.1% 
6MWT (m) 384-+117 440-+64*** 419_+57"** 434±82*** +13.0% 
LVEDD (mm) 66±11 64±11 64-+141 63-+12 -4.6% 
LVESD (mm) 56-+12 52_+13 52-+14 50-+14 -10.7% 
FS(%) 0.17+0.08 0.20_+0.08 0.19 -+ 0.07 0.22_+0.09 +29.4% 
EF(%) 0.30_+0.10 0.34_+0.11 ** 0.34_+0.12" 0.36-+0.12"* +20.0% 
Men (n=51) Baseline 3 months 6 months 12 months Change- 
baseline to 
12 months 
NYHA 2.9+0.6 2.3_+0.7** 2.1_+0.8"* 2.1_+0.7 ... .  -27.6% 
6MWT (m) 442 -+ 66 498 _+ 90 * 489 _+ 105 * 483 _+ 194 * + 9.3 % 
LVEDD (mm) 74_+12 73-+14 73+14"  72_+15"* -2.7% 
LVESD (mm) 63-+13 61-+16 60±17 60-+17 -4.8% 
FS(%) 0.16_+0.08 0.17_+0.09" 0.19±0.08"** 0.19±0.09"** +18.8% 
EF(%) 0.27±0.11 0.30_+0.14" 0.32_+0.14"* 0.33_+0.14"** +22.2% 
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ANOVA analysis: * p < 0.05, ** p < 0.01, *** p < 0.001 
Conclusion: Both men and women tolerated carvedUol equally well and had a similar 
side effect profile. Men and women who received carvedilol for greater than 12 months 
benefited similarly with regards to an improvement in their NYHA functional class, 
greater 6 minute walk test (6MWT) distances, and echocardiographic parameters includ- 
ing smaller left ventdcular end-diastolic diameter (LVEDD), smaller left ventdcular end- 
systolic diameter (LVESD), improved fractional shortening (FS) and improved ejection 
fraction (EF). These benefits were seen as eady as 3 months after commencing 
carvedilol. Women received at least as much benefit as the men, Therefore, if the side 
effects can be tolerated it is beneficial for both men and women to remain on carvedilol. 
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1206-146 Aging Produces Marked Viscoelastic Alterations in 
Viable Myocardium 
Francis C. Nao, Scott Handley, John Allen, Mark McLean, Samuel Wickline, Washington 
University School of Medicine, SL Louis, Missouri. 
Age is a leading prognostic factor for post myocardial infarction mortality. Ventdcular 
remodeling in viable myocardium can ultimately compromise cardiac function; but the 
effect of aging on the remodeling process is not well understood. Objective: To evaluate 
the effect of aging on remodeling using an experimental aging animal model. Methods: 
Myocardial infarction was induced by LAD ligation in Fischer 344 aging rats at 3 and 18 
months of age. Sham procedures were performed in both groups as a control. High-reso- 
lution acoustic microscopy was conducted at 50 MHz on excised LV segments 3 months 
post infarction. Quantification of the integrated backscatter (IB) power, a marker of the 
viscoelastic index, was performed on viable regions of myocardium in the 3 and 18 
month old rat groups and their respective shams. Results: The IB for the viable zone in 
the 16 month old rats was significantly higher than the IB for the viable region in the 3 
month old rats, respectively, (-45.4±1.0 dB vs -48,4±0.8 dB , p < 0.05). In addition, the 
difference in IB between the sham regions and the viable zones was approximately two 
times higher in the old rats than in the young rats, (4.3 dB vs 1.4 dB, p <0.06). Of note, 
the IB of the regions in the young and old shams were statistically similar, (-49.8±0,9 dB 
vs -49.7±1.1 dB, p = NS). Conclusion: This data suggests that in the setting of post myo- 
cardial infarction remodeling, the viable myocardium in older hearts undergo a significant 
increase in viscoelastic index over that found in younger hearts. This increase was not 
present in the young and old sham populations. Therefore, aging potentiates the change 
in the viscoelastic index that occurs in viable myocardium post myocardial infarction and 
subsequently may effect both systolic and diastolic function. These findings may further 
our understanding of the effects of aging on ventdcular emodeling. 
1206-147 Compensatory Changes in Atrial Function With Aging 
Liza Thomas. Kate Levett, Dominic Y. C. Leung, Nelson B. Schiller, David L. Ross, 
Westmead Hospital, Sydney, NSW, Australia, Liverpool Hospital, Sydney, NSW, 
Australia. 
Aim: Atrial function is clinically relevant but assessment is difficult. Doppler Tissue Imag- 
ing (DTI) has quantified intrinsic ventricular contraction. We hypothesized that DTI could 
measure atrial contraction as a marker of atrial function. 
Methods: 92 healthy subjects (no history of hypertension, diabetes, ischemic heart dis- 
ease, not on cardioactive medications) (Grp 1 :under 50yrs;Mean:32yrs): n=47) and (Grp 
2:over 50yrs; Mean:63yrs): n=45) with normal transthoracic echocardiogmms were stud- 
ied. Atrial contraction velocity in late diastole (A') was measured by PW Doppler DTI from 
apical 4C view by sampling at the septal mitrel annulus. Echo parameters of atrial func- 
tion including mitral A wave velocity (A vel), A wave velocity time integral (AVTI), atrial 
fraction ((A VTI/'rotal inflow VTI ) x 100%) and Atrial Ejection Force (Aef) (0.5x rho x 
mitral orifice area x(A vel)2 ) were measured. From apical 4C and 2C views, maximum 
LA volume in venthcular systole (LAESV) and minimum LA volume in diastole(LAEDV) 
were calculated by the biplane method of discs. LASV= LAESV-LAEDV. 
Results: DTI velocity of A' was higher in Grp 2 vs Grp 1. (9.8±1.8 vs 8.5±1.5 cm/sec; 
p=0.0005). The A vel (0.6± 0.14 vs 0.79±0.2 m/sec; p=0.0001), A VTI (8±3.1 vs 
11.2±4cm; p=0.0001), atrial fraction (35.4±8.7vs 46.5±8;p=0.0001) and Aef (14±8 
vs22±12; p=0.003) were higher in Grp 2. A' vel correlated with Aef and atdal fraction 
(Spearmean rank p=0.04 and p=0.0075 respectively). Multiple regression analysis for 
predictors of A' vel, atrial fraction and Aef showed that age was the single common pre- 
dictor. In Grp 2, 26/45 pts had E/A < 1 suggesting impaired relaxation while present in 
only 2/47 in Grp 1. LAESV, LAEDV and LASV were not significantly different in the 2 
groups. Thus, atrial contraction velocity increased with age suggesting that this was a 
normal compensatory mechanism to overcome age associated decline in LV compliance. 
Conclusions: 1) DTI (A' vel) can be used to quantify atrial contraction; 2) A' vel contrib- 
utes at least in part to atrial fraction and Aef; 3) A' velocity increases in "normal" older 
individuals to compensate for decreased LV compliance;4) normal aging does not 
increase atrial size significantly. 
